跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Emla® - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Emla®
Approved
STANDARD
Emla®
Recipharm Karlskoga AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2548aae269f95629
Company
Recipharm Karlskoga AB
Type
Standard
Approval Details
Approval Id
2548aae269f95629
Drug Approval Philippines Name
Emla®
Product Name
Emla®
Registration Number
DR-XY3694
Brand Name
Emla®
Generic Name
Lidocaine hydrochloride + Prilocaine hydrochloride
Dosage Form
Cream
Dosage Strength
25mg/ 25mg (5%)
Manufacturer
Recipharm Karlskoga AB
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/recipharm-karlskoga-ab
Issuance Date
01 June 2021
Expiry Date
01 August 2026
Pharmacologic Category
Local Anesthesia
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2548aae269f95629
Type
Standard
Back to Philippines FDA Approvals